- Home
- / HDL Therapeutics
- / Executives
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
HDL Therapeutics's Chairman of the Board, CEO is Michael M. Matin. HDL Therapeutics's key executives include Michael M. Matin and 5 others.
Need Data?
Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.